HDAC4型
钙化
血管平滑肌
组蛋白脱乙酰基酶
细胞质
细胞生物学
下调和上调
生物
医学
内分泌学
内科学
组蛋白
生物化学
基因
平滑肌
作者
Alon Abend,Omer Shkedi,Michal Fertouk,Lilac Caspi,Izhak Kehat
标识
DOI:10.1161/res.119.suppl_1.136
摘要
Background: Arterial calcification and valvular calcifications are associated with significant morbidity and mortality. Studies have now conclusively showed that an osteochondrogenic differentiation of vascular smooth muscle cells (VSMC) is a key mechanism in the development of vascular calcification, opening a direction for therapeutic interventions. Objective: To identify the role, subcellular location and mechanism of action of class IIa Histone deacetylase 4 (HDAC4) in vascular calcification Methods and Results: We used VSMCs, ex-vivo mouse aortic rings and human calcified aortic valves to show that HDAC4 is upregulated in vascular and valve calcification. Despite being exclusively cytoplasmic in VSMCs we show using both gain- and loss- of function approaches that HDAC4 is a positive regulator of the process. The cytoplasmic location of HDAC4 is controlled by the activity of salt inducible kinase (SIK) and the inhibition of SIK sends HDAC4 to the nucleus and inhibits the ossification process. In the cytoplasm HDAC4 binds to the LIM domains of the adaptor protein ENIGMA (Pdlim7) to promote vascular ossification of VSMCs. Conclusions: Here we identified a new role and a new mechanistic paradigm for HDAC4. We provide multiple lines of evidence that the cytoplasmic activity of HDAC4 promotes vascular calcification, and identify HDAC4, SIK and ENIGMA as mediators of this pathological process
科研通智能强力驱动
Strongly Powered by AbleSci AI